Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
Marksans' OTC Famotidine Tablets USP are acid reducers
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
Subscribe To Our Newsletter & Stay Updated
